AYUSH-64, A polyherbal formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), is found to be useful in the treatment of asymptomatic, mild, and moderate COVID-19 infection as an adjunct to standard care, through various Randomized Controlled Trials conducted in India.

Share this :